Intrinsic Value

Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

-0.86 (-15.96%)

Enterprise Value -750.18
Net Debt -50.41
Equity Value -699.77
Shares Outstanding 629.81
Equity Value Per Share -1.11

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt